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Abstract  
The current study provides a complete MRI analysis of thickness throughout the cerebral 
cortical mantle in patients with schizophrenia (SZ) and rigorously screened and matched 
unaffected relatives and controls and an assessment of its relation to psychopathology and 
subjective cognitive function. We analyzed 3D-anatomical magnetic resonance imaging data 
sets, obtained at 3 Tesla, from three different subject groups: 25 SZ patients, 29 first-degree 
relatives and 37 healthy control subjects. We computed whole-brain cortical thickness using 
the Freesurfer software and assessed group differences. We also acquired clinical and 
psychometric data. The results showed markedly reduced cortical thickness in SZ patients 
compared with controls, most notably in the frontal and temporal lobes, in the superior 
parietal lobe and several limbic areas, with intermediate levels of cortical thickness in 
relatives. In both patients and relatives, we found an association between subjective cognitive 
dysfunction and reduced thickness of frontal cortex, and predisposition towards hallucinations 
and reduced thickness of the superior temporal gyrus. Our findings suggest that changes in 
specific cortical areas may predispose to specific symptoms, as exemplified by the association 
between temporal cortex thinning and hallucinations. 
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1. Introduction 
Cortical thickness is defined as the local or average distance between the white matter 
surface and the pial surface of the cortex. It correlates with the number of neurons and the 
neuropil within an ontogenetic column, the cohort of cortical neurons that originate from a 
single neuronal progenitor (Rakic, 2008). Measurement of cortical thickness may thus allow 
probing alterations in brain growth and maturation (Magnotta et al., 1999; Salat et al., 2004; 
Sowell et al., 2001; Sowell et al., 2003), which are increasingly being discussed as potential 
pathogenetic mechanisms of schizophrenia (SZ) (Thompson et al., 2004). Cortical thickness 
mapping in SZ has indeed revealed thinning of the cortical sheet, particularly in parts of the 
frontal and temporal lobes (Goldman et al., 2009; Haukvik et al., 2009; Kuperberg et al., 
2003; Lawyer et al., 2008; Venkatasubramanian et al., 2008), and some of these changes seem 
to progress during the transition from prodromal to clinical states (Wood et al., 2008). The 
putative genetic contribution to reduced cortical thickness in SZ can be studied by including 
patients’ first-degree relatives, where genetic traits can potentially be observed without the 
confounding factors of medication or illness effects. However, only few studies have 
compared cortical thickness measures across SZ patients, relatives and controls (Calabrese et 
al., 2008; Yang et al., 2010; Goldman et al., 2009; Harms et al., 2010;), and of these only the 
latter two mapped the whole cortical mantle.  
Yang et al. (2010) reported whole-brain significant differences between relatives and 
controls, and these were confined to left parahippocampal and inferior occipital gyrus. Some 
of the studies that examined only subregions of cortex reported thinner cortex in relatives 
compared to controls in the frontal lobe (Harms et al., 2010; Yang et al., 2010), specifically in 
the cingulate gyrus (Calabrese et al., 2008; Goghari et al., 2007b, 2007a) and in the temporal 
lobe (Calabrese et al., 2008; Goghari et al., 2007b, 2007a; Gogtay et al., 2007; Yang et al., 
2010), but these results were not corrected for comparisons across the whole brain and in 
some studies may have been affected by the inclusion of individuals with psychiatric 
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symptoms in the relatives groups (Calabrese et al., 2008; Goghari et al., 2007b, 2007a; Harms 
et al., 2010; Yang et al., 2010). 
Inconsistencies across studies may be further explained by differences in magnet field 
strength and imperfect matching for gender and handedness. Both handedness and gender 
have been associated with structural changes in schizophrenia (e.g., Nopoulos et al., 1997, 
Gur et al., 1999; Gur et al., 2004). In the present whole-brain study of cortical thickness 
differences between schizophrenia patients, unaffected relatives and controls without family 
history of mental disorder, we therefore applied rigorous exclusion and matching criteria. 
Furthermore, we scanned at a field strength of 3 Tesla on the basis that the improved signal-
to-noise ratio is particularly beneficial for the white/grey matter contrast that is crucial for 
accurate cortical segmentation (Kruggel et al., 2010). Many previous studies (Harms et al., 
2010; Goldman et al., 2009; Yang et al., 2010) assessed cortical thickness using 1.5 Tesla 
systems. 
We also explored the functional significance of any changes in cortical thickness 
through correlation with clinical and subclinical symptoms. Several studies have shown 
associations between structural abnormalities and symptom severity in SZ patients (Gaser et 
al., 2004; Levitan et al., 1999; Oertel et al., 2010; Sumich et al., 2005; Venkatasubramanian et 
al., 2008; Venkatasubramanian et al., 2011), and specifically between cortical thinning in SZ 
and impairments of verbal learning, working memory and executive control (Ehrlich et al., 
2011; Hartberg et al., 2010). Although few studies of the cortical thickness studies in relatives 
assessed correlations with cognitive performance (Harms et al., 2010) and acute symptoms 
(Goldman et al., 2009; Yang et al., 2010), associations with subclinical symptoms such as 
propensity to develop hallucinations, which is increased in relatives compared to the general 
population (Kendler et al., 1995), have not been addressed. Subclinical symptoms are of 
particular interest, though, because cortical thickness is being explored as a structural trait 
marker of SZ and thus potential associations with psychological traits might be more likely 
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than those with acute symptoms. We therefore tested, for the first time, whether cortical 
thickness changes would correlate not only with clinical symptoms in SZ patients but also 
with subclinical traits in relatives.  
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Methods and Materials 
Participants  
We included 31 SZ patients (mean age: M = 38.00 [SD: 11.24]) diagnosed with paranoid 
schizophrenia according to DSM-IV criteria (APA, 2000). All patients were in-patients of the 
Department of Psychiatry, Psychosomatic Medicine and Psychotherapy of Frankfurt 
University. All patients were treated with atypical antipsychotics, and four patients 
additionally with typical antipsychotic medication at the time of testing. To ensure that the 
results of our study were not modulated by a specific medication effect from typical 
antipsychotics (Dazzan et al., 2005), we repeated the analysis for group differences on the 
structural measures without the four patients with typical antipsychotics. Mean duration of 
illness was 12.48 years [SD = 7.33] 
 
---------------------------------------Insert table 1 about here--------------------------------------------- 
 
29 first-degree relatives (mean age: M = 40.34 [SD = 15.84]) and 37 healthy controls 
(mean age: M = 39.36 [SD = 9.97]) also participated in the study (see Table 1 for further 
details). Contact to the relatives was established through participating patients, from a support 
group for relatives of SZ patients, through newspaper articles, flyers and advertisements in the 
hospital. The first-degree relatives were requested to bring a letter from the psychiatrist 
treating the patient of the affected family to confirm the diagnosis. The relative group 
included parents (n = 16) and siblings (n = 13) of other SZ patients than those included in the 
study.  
The control group was matched with the groups of patients and relatives for 
handedness (all right handed; The Edinburgh Inventory; (Oldfield, 1971), age, sex and 
parental education. Statistical tests (ANOVA, Scheffé post-hoc contrast analyses) for 
differences between the groups regarding age and years of education revealed no significant 
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differences (p > .05). Chi-square test showed that gender distribution was equal across groups 
(p >.05). Exclusion criteria for control and relative participants were any psychiatric disorder 
according to DSM-IV, left-handedness, current drug-abuse, any neurological pathology and 
inability to provide informed consent. None of the controls had any positive family history of 
schizophrenia. 
The anatomical MRI scans were reviewed by a neuroradiologist who did not find 
underlying pathology. Participants were provided with a description of the study and gave 
written informed consent before participation. Experimental procedures were approved by the 
ethical board of the medical department of the Johann Wolfgang Goethe-University, 
Frankfurt/Main, Germany. For further use in a separate study, additional functional and 
diffusion tensor imaging were performed (see (Oertel et al., 2010; Rotarska-Jagiela, 2009). 
 
Assessment of psychopathology 
The Structured Clinical Interview for DSM-IV (German version, (Wittchen et al., 
1996) was carried out in schizophrenia patients, in controls and first-degree relatives. 
Relatives of individuals with SZ or control participants who met criteria for psychiatric or 
neurological disorders were excluded from the study. SZ patients had no other concurrent 
psychiatric diagnoses in addition to schizophrenia. The final sample (n = 29) included only 
first-degree relatives without any psychiatric, neurological or personality disorders. Current 
psychopathology of the SZ patients was assessed using the Positive and Negative Symptom 
Scale (PANSS) (Kay et al., 1987) (view table 1 for further details).  
All patients had a history of auditory hallucinations as assessed by the PANSS 
interview and a semi- structured interview based on the criteria proposed by Aggernaes 
(Aggernaes, 1972) to assess the contents, phenomenology, severity and occurrence of 
hallucinations in more detail. The last period of auditory hallucinations ranged from 13 days 
to 8 months before the scanning. None of the patients reported any hallucinations while they 
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were scanned.  
         All participants were screened for predisposition towards hallucinations with the 
Revised Hallucination Scale (RHS; (Morrison et al., 2002). Subjective cognitive dysfunction 
was assessed using the Eppendorf Schizophrenia Inventory (ESI; (Mass et al., 2000). The ESI 
assesses psychosis-related symptoms and subjective cognitive dysfunction in schizophrenia 
and integrates over four weeks. Participants have to rate 40 items based on 4 subscales 
(attention and speed impairment, ideas of reference, auditory uncertainty and deviant 
perception on a 4-point-Likert scale). The ESI is considered to be a sufficiently reliable and 
valid instrument (Cronbach’s alpha: .60-.90; Mass et al., 2000). 
Controls and relatives also completed the German version of the Schizotypy 
Personality Questionnaire (SPQ; (Klein, 1997; Raine, 1991). The SPQ is a 74 item self-report 
measure that was designed to measure schizotypal traits in non-clinical populations. Items 
address unusual perceptual and cognitive experiences and subjects are required to indicate 
whether an item is appropriate to their own situation by marking True or False. True-scores 
are summed to obtain a total score with a higher total score implying the presence of more 
schizotypal experiences. (Klein, 1997) suggested a two-factor model of the SPQ, where the 
original factors were reconfigured into a cognitive-perceptual factor and an interpersonal 
factor. We computed ANOVAs with RHS and ESI as dependent variable and group as fixed 
factor with three levels (controls, relatives, SZ patients) (Table 1). The psychometric data 
from the participants of this study contributed to the larger sample documented in (Oertel et 
al., 2009). 
 
Data acquisition and image processing 
For anatomical measurement, we acquired a high-resolution T1-weighted MDEFT sequence 
(Deichmann et al., 2004) (176 slices, 1x1x1 mm3, matrix size 256*256, Slice thickness 1mm, 
Flip angle: 16°) covering the whole brain on a Siemens Magnetom Allegra 3 Tesla MRI 
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system (Siemens Medical Systems, Erlangen, Germany) at the Frankfurt University Brain 
Imaging Center, Germany. Analysis of structural MRI data was performed using the software 
tools of MATLAB® (The Mathworks Inc., Natick, MA, USA), Freesurfer® (Freesurfer 
Troubles shooting Reconstruction work flow), and QDec®. 
 
Methods and Materials 
Cortical thickness was estimated at each vertex across the brain surface using a semi-
automated approach implemented in the Freesurfer software 
(http://surfer.nmr.mgh.harvard.edu/) (Dale et al., 1999; Fischl et al., 2001; Fischl et al., 1999; 
Salat et al., 2004; Segonne et al., 2004; Segonne et al., 2005). Thickness measurements were 
obtained by reconstructing representations of the gray matter (GM) / white matter (WM) 
boundary and the cortical surface and then calculating the distance between those surfaces at 
each point across the cortical mantle (Dale et al., 1999). The analysis includes several 
segmentation steps to create white matter (WM), grey matter (GM) and pial borders for each 
individual brain. The segmentation included a Talairach transformation, manual stripping of 
the optical nerve and the dura mater, and an automated strip of the skull and subcortical 
structures (Segonne et al., 2004). For quality control, all 97 segmentations were inspected, 
manually corrected and re-inspected as described by (Fischl et al., 2001) and (Goldman et al., 
2009) by three independent raters (V.O., C.K., B.R.). For inter-rater reliability, raters, blinded 
to group membership, independently performed the correction steps. Inter-rater reliability 
computed by using 5 randomly selected brains and corrected by each of the 3 raters reached 
.93 to .96 for all brains. In addition, intra-rater reliability for five other, randomly selected 
brains was good (rater 1: .95, rater 2: .95, rater 3: .96). 
We then applied a validated surface reconstruction algorithm (Dale et al., 1999; Han 
and al., 2006; Rosas, 2002) to the volume data. Briefly, WM segmentations were first 
produced (Dale et al., 1999), using information from the subcortical segmentations to also fill 
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in areas that commonly produce topological defects (such as basal ganglia and lateral 
ventricle). Cutting planes were used to isolate each cerebral hemisphere, and final binary WM 
masks were produced. Tessellation was then performed to produce a triangle-based mesh of 
the WM surface, and a smoothing algorithm was used to alleviate the voxel-based nature of 
the initial curvature (Dale et al., 1999). Topological defects in the surfaces were then 
corrected using an automated topology fixer (Segonne et al., 2005). Preprocessing involved a 
registration to a reference brain, which is an average template of all anatomies of our study. 
This average brain was used as a template for the visualization of the results.  
The surfaces produced are in Talairach space, allowing direct, anatomically accurate 
measurements of thickness but also necessitating an algorithm for surface-based inter-subject 
registration. To achieve this, surfaces were spherically inflated (Fischl et al., 1999), and 
spherical surfaces for each subject were registered to a common space spherical deformation 
guided by automatically defined cortical features derived from a population atlas (Fischl et 
al., 1999). Final surface data were then parcellated into cortical regions using an automated 
algorithm, which used a manually labelled training data set, as well as knowledge of curvature 
and the spatial relationship between regions (Desikan et al., 2006; Fischl et al., 2001). The 
atlas (Desikan et al., 2006) included 33 gyral regions of interest. At the end of this process, 
each subject’s reconstruction was again visually inspected for gross topological inaccuracies. 
Cortical thickness was calculated for each vertex in the triangulated surfaces by finding the 
point on the white matter surface that was closest to a given point of the pial surface (and vice 
versa) (Fischl and Dale, 2000; Han and al., 2006).  
 
Statistical analysis 
Node-by-node contrasts of cortical thickness were performed for healthy controls versus SZ 
patients, controls versus unaffected relatives, and SZ patients versus unaffected relatives. For 
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this, an average normal control surface was generated, and thickness data from each subject 
were mapped to this average surface and smoothed using a standard gaussian filter. Finally, 
each contrast was entered into an ANCOVA, including diagnosis, intracranial volume (ICV; 
(Prvulovic et al., 2002) sex and age as covariates. Results were thresholded at a surface-wide 
p < 0.05. We corrected for multiple comparison with permutation testing with Monte Carlo 
simulation and cluster analysis, as implemented in Freesurfer 4.50. In this procedure, the 
analysis is repeated 10,000 times with arbitrary group labels in order to generate a distribution 
under the null hypothesis of no difference between groups. This distribution then yields the 
minimum cluster size for the threshold-based comparison. The basic assumption of this 
approach is that random fluctuations of signal (in this case cortical thickness differences) are 
unlikely to cluster in space (Nichols and Holmes, 2002), and its implementation in Freesurfer 
is a standard procedure for the comparison of cortical thickness data between patients and 
controls (Pereira et al., 2011).   
In addition, we computed the chlorpromazine equivalence doses for the patients’ 
antipsychotic medication (Woods, 2003). Individual doses ranged from 200 to 1600 mg/d 
(mean: 613 [399]). We computed the correlation between the chlorpromazine equivalents and 
the cortical thickness indices to investigate a possible medication effect (Pearson bivariate 
correlation, 2-tailed). We also computed bivariate correlation analysis (Spearman rank 
correlation, 2-tailed) between the predisposition towards hallucinations (RHS, (Morrison et 
al., 2002), the subjective cognitive dysfunction (ESI; Maß et al., 2000), the schizotypy (SPQ; 
(Klein, 1997) and the individual psychopathology (PANSS, (Kay et al., 1987) with the 
cortical thickness indices.  
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3. Results 
3.1 Statistical comparison between the subject groups 
The group differences in psychometric data are documented in Table 1. For the cortical 
thickness, we found significant group differences in frontal, temporal and limbic areas (Table 
2, Fig. 1). Patients showed significant cortical thinning in comparison with relatives and 
controls bilaterally in the inferior frontal gyrus, in the left superior temporal gyrus (BA 41) 
and the right lingual gyrus. Here, the contrasts between relatives and controls were not 
significant.  
Both patients and relatives showed significantly lower cortical thickness in 
comparison with controls bilaterally in the middle frontal gyrus, in the left precentral gyrus, in 
the right superior temporal gyrus (BA 41), the left inferior parietal lobule, the right insula, the 
left anterior cingulate and bilaterally in the hippocampus and parahippocampal gyrus. 
Thickness values in these areas did not differ between relatives and patients.  
Several other areas showed a continuum of cortical thickness across subject groups 
(CON> REL > PAT). This pattern of significant differences between all groups was observed 
in the right inferior frontal gyrus, the right precentral gyrus, the middle temporal gyrus 
bilaterally and the superior parietal lobule bilaterally. Conversely, we did not observe higher 
cortical thickness values in patients or relatives compared to controls in any area, even when 
lowering the threshold to p = 0.1.  
In general, our results of the current study are in line with the estimates for cortical 
thickness (Fischl and Dale, 2000), with the lowest value for patients in the right inferior 
frontal gyrus (1.89 mm) and the highest value for controls in the left superior temporal gyrus 
(3.98 mm). We computed power calculations on the cortical thickness findings (Cohen, 1992) 
for any contrast (controls vs. patients / controls vs. relatives / relatives vs. patients). These 
calculations revealed effect sizes between r = 0.45 and r = 0.61 for all involved areas.  
---------------------------------Insert table 2 and figure 1 about here------------------------------------ 
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3.2 Correlation between cortical thickness and symptom severity 
Because of previous reports links between cortical thickness in the temporal lobe with 
hallucinations (Kuperberg et al., 2003), we computed the correlation between RHS and 
PANSS and left superior temporal cortex thinning. No significant correlation was found 
between any of the PANSS scores and cortical thickness in any of the assessed areas (p > 
0.05). However, we did find a significant correlation between the predisposition towards 
hallucinations (RHS) and left superior temporal cortex thinning in patients (rho = 0.43, p = 
0.03) and relatives (rho = 0.38, p = 0.04), but not in controls (rho = 0.21, p > 0.05).  
Following Hartberg et al (2010) and Ehrlich et al. (2011), who reported relationships 
between cortical thinning in frontal regions and cognitive functioning in patients with 
schizophrenia, we computed bivariate correlation analysis with ESI (subjective cognitive 
dysfunction) and cortical thickness measures for the frontal areas (bilateral inferior and 
middle frontal gyrus). The results showed that the inferior frontal gyrus cortical thickness 
bilaterally was significantly correlated with the subjective cognitive dysfunction in SZ 
patients (rho = 0.48, p < 0.01) and relatives (rho = 0.40, p < 0.01), but again not in controls 
(rho = 0.24, p > 0.05). All other computed correlations were non-significant (p > 0.05).  
Moreover, correlation analysis between the total score of the schizotypy questionnaire 
(SPQ) was not correlated with any of the cortical thickness scores in any of the groups. Only 
the cognitive-perceptual factor was significantly associated with inferior frontal gyrus cortical 
thickness bilaterally in the relatives group (rho = 0.47, p < 0.01). Finally, parahippocampal / 
hippocampal volume was significantly associated with duration of illness in our patient group 
(rho = 0.55, p < 0.01). 
 
4. Discussion 
We demonstrate marked cortex thinning in SZ patients and relatives, most notably in frontal 
Cortical thickness in schizophrenia 
Oertel-Knöchel et al. 
14 
and temporal lobes, in the superior parietal lobe and several limbic areas. We show, for the 
first time, a significant association between clinical and cognitive traits of SZ and cortical 
thinning in frontal and temporal regions in unaffected relatives. 
 
Cortical thinning in SZ patients: frontal lobe, temporal lobe and limbic areas 
Our findings cortical thinning in SZ patients replicates previous reports for frontal (Kuperberg 
et al., 2003; Narr et al., 2005; White et al., 2003) and temporal (e.g., (Kubota et al., 2011; 
Kuperberg et al., 2003) regions of SZ patients. Only one study (using a non–surface-based 
method) has found no reduction in frontal regions of SZ patients, but they investigated first-
episode patients who would have been less affected by any progressive volume loss 
(Wiegand, 2004). Our findings are also in line with volumetric studies, which have indicated 
volume reduction in SZ mainly in prefrontal areas (Henn and Braus, 1999; Honea et al., 2005; 
Wright, 2000) and the superior temporal gyrus (Kuperberg et al., 2003; Narr et al., 2005; 
Oertel et al., 2010; White et al., 2003), and middle temporal gyrus (Goldman et al., 2009; 
Henn and Braus, 1999; Honea et al., 2005; Wright, 2000) and medial temporal lobe (Henn 
and Braus, 1999; Honea et al., 2005; Wright, 2000). However, although prefrontal and 
temporal regions are generally the most strongly implicated in schizophrenia, cortical volume 
loss was not confined to these regions, which is again consistent with previous literature 
(Goldman et al., 2009; Henn and Braus, 1999; Honea et al., 2005; Wright, 2000). This 
supports the idea that the predominant functional impairment of prefrontal and temporal 
structures in schizophrenia may not be exclusively due to localized structural-functional 
effects, but also mediated through the extensive interconnections that these regions maintain 
with the rest of the brain (Goldman et al., 2009; Harrison and Weinberger, 2005; Meyer-
Lindenberg, 2009; Weinberger and Lipska, 1995).  
Our SZ sample also showed significant thickness reductions in parahippocampal 
gyrus/hippocampus in comparison with controls. Previous results in the parahippocampal 
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gyrus were equivocal, with some studies reporting reduced thickness (Kuperberg et al., 2003; 
Murakami et al., 2010) but others failing to find parahippocampal gyrus thinning in first-
episode schizophrenia (Narr et al., 2005), in the first 5 years of childhood-onset schizophrenia 
(Thompson, 2004) and in chronic SZ patients (Goldman et al., 2009). The inconsistencies in 
the literature may be the result of inter-individual variability and different morphometric 
methods, and the present approach of cortical thickness mapping at 3 Tesla may be have been 
more sensitive than some of the previous studies.  
The cortical thickness reductions observed in imaging studies are plausible 
considering the findings of post-mortem studies, which have indicated an overall decrease in 
brain size (Bruton et al., 1990), volume reduction of the cerebral hemispheres (Pakkenberg, 
1993), and several regional alterations, e.g., reduced size of temporal lobe structures (Vogeley 
et al., 1998). In addition to reduced size and number of neurons, their positioning across 
layers was also altered in various brain regions in post-mortem brains from SZ patients 
(Harrison, 1999). (Harrison, 1999) suggested that these alterations may indicate a reduced 
number of synaptic contacts in the affected areas. Another possibility is that neuronal 
apoptosis might contribute to gray matter alterations in schizophrenia (Glantz et al., 2006). 
Post-mortem studies of schizophrenia indicate that apoptotic regulatory proteins and DNA 
fragmentation patterns are altered in several cortical regions (Benes et al., 2003) and (Jarskog 
et al., 2004).  
However, the underlying pathology of cortical thinning in SZ is not yet well 
understood (DeLisi et al., 2006; Harrison, 1999; Keshavan et al., 2008). Higher cell density 
(Pakkenberg, 1993; Selemon et al., 1995), smaller neuropil (Selemon et al., 1998) and 
reduced neuron size (Rajkowska et al., 1998) in the cortical gray matter have been suggested 
as potential explanation, but these findings were not consistently confirmed (Arnold et al., 
1995; Cullen et al., 2006; Harrison, 1999). Cortical thickness does not need to be synonymous 
to volume (Goldman et al., 2009), especially if altered gyrification patterns are taken into 
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account (Tepest et al., 2008). Furthermore, findings of (Murakami et al., 2010) – as well as 
the present study - indicate that the duration of illness might be one additional factor 
contributing to volumetric and cortical thickness findings, which may explain some of the 
inconsistencies in the previous literature highlighted above. Another potential confound, as 
pointed out by (Goldman et al., 2009), is that structural changes measured with MRI may not 
correspond to cellular changes but rather to changes in tissue fluid levels and vascularization.  
One potential limitation of studies investigating brain morphology in SZ patients is the 
confounding effect of present or past antipsychotic medication. Studies in monkeys treated 
long-term with antipsychotic drugs have demonstrated that cortical volume is reduced by 
these agents (Dorph-Petersen et al., 2005). (Tost et al., 2010) reported an induction of 
reversible striatal volume changes and structural-functional decoupling in motor circuits 
within hours through acute D2 receptor blockade. However, cortical volume reduction in 
previous patient studies mainly resulted from typical antipsychotics (Dazzan et al., 2005), 
whereas our patients were all treated with atypical antipsychotics. To control for this factor, 
we performed an additional analysis of the cortical thickness without the four patients with 
additional typical antipsychotics, which showed similar results to the main analysis. We 
further controlled for medication effects by correlation analysis with chlorpromazine 
equivalents in our patient group.  
 
Cortical thinning in unaffected first-degree relatives 
Our unaffected first-degree relatives showed cortical thickness reductions in frontal, 
precentral, temporal, parietal and limbic (insula, anterior cingulate, hippocampal gyrus / 
hippocampus) areas. Temporal, parietal and cingulate cortical thinning in unaffected relatives 
of SZ patients has been shown previously (Calabrese et al., 2008; Goghari et al., 2007b, 
2007a; Goldman et al., 2009; Yang et al., 2010). However, the literature is contradictory with 
respect to altered frontal and especially prefrontal lobe structure (Goldman et al., 2009; 
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Callicott et al., 2003; Goghari et al., 2007b, 2007a).  
Reasons for such contradictory findings may be difference in sample selection, small 
sample sizes, heterogeneous study groups and sensitivity of the imaging procedure. We 
recruited relatives of patients from other patients than those included in this study, which is an 
accepted procedure (Repovs et al., 2011). Although in some respects it may be even better to 
recruit relatives of the study patients (Venkatasubramanian et al., 2011), this poses additional 
difficulties with respect to participant matching and would induce a bias in the patient group 
(by confining it to those who have siblings). Assuming that for all their genetic heterogeneity, 
patients with schizophrenia have consistent abnormalities in the brain (e.g. cortical thinning), 
it makes sense to probe the same effects in a relative group who also carry schizophrenia risk 
genes (although not necessarily the same) but are not affected by secondary effects of the 
illness. The theoretical rationale behind this is that the various risk genes will converge on 
biological pathways, for example those regulating brain development (Owen et al., 2010).  
Some previous studies did not compare patients and relatives directly, but only 
relatives and controls (Goghari et al., 2007b, 2007a; Gogtay et al., 2007; Mattai et al., 2011). 
We would suggest that it is important to compare across all three groups (controls, unaffected 
relatives and patients) to confirm that observed changes in relatives are actually trait markers 
of the disorder rather than, for example, indicators of resilience. There is some indication that 
cortical abnormalities in relatives of schizophrenia patients are most prominent during brain 
development (Gogtay et al., 2007). (Gogtay, 2008) reported that younger healthy siblings of 
SZ patients showed significant GM deficits, but that these changes disappeared by age 20. 
This dynamic pattern, which has recently been replicated (Mattai et al., 2011) may indeed 
indicate preserved plasticity and resilience in the non-psychotic siblings (Gogtay, 2008).  
 
Association with symptom severity and cognitive function 
We tested whether altered cortical thickness may predispose patients to specific symptoms, 
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probing for subclinical psychotic symptoms in all participants. We provide evidence for a 
significant correlation between predisposition towards hallucinations (RHS) and left superior 
temporal cortex thinning in both patients and relatives Our results revealed no significant 
association between state markers of symptom severity, as measured with the PANSS, and 
cortical thinning. (Goldman et al., 2009) report only an association between left superior 
temporal cortex thinning and the general psychopathology subscale of the PANSS in patients, 
and did not address associations in the relatives group or use scales assessing trait markers of 
prepsychotic symptomatology as used in the present study (RHS, ESI, SPQ).  
Our finding of an association between the subjective cognitive dysfunction (ESI) and 
perceptual-cognitive factor (SPQ) (only relatives) and thinning of frontal areas in patients and 
relatives expand on the findings by (Hartberg et al., 2010) and (Ehrlich et al., 2010), who 
reported a significant positive relationship between volume loss in frontal, temporal and 
occipital regions and tests for verbal IQ, verbal learning and executive functions in SZ 
patients.  
 
Conclusion 
The main finding of the present study was widespread cortical thinning in unaffected relatives 
of patients with schizophrenia compared to healthy matched controls. These were largely 
intermediate to the differences found between patients and controls, suggesting the possibility 
that they constitute an endophenotype of the disorder (Gottesman and Shields, 1973; 
Gottesman and Gould, 2003; Shields and Gottesman, 1972; Van Os and Jones, 2001). 
Interestingly, thinning in frontal areas correlated with cognitive complaints and that in 
temporal areas with the propensity to develop hallucinations. Our findings are relevant for 
neurodevelopmental models of schizophrenia and indicate new quantitative trait loci for 
Cortical thickness in schizophrenia 
Oertel-Knöchel et al. 
19 
association studies that explore the genes that confer vulnerability to abnormal brain 
development in SZ.   
Cortical thickness in schizophrenia 
Oertel-Knöchel et al. 
20 
Acknowledgments: 
MRI was performed at the Frankfurt Brain Imaging Center, supported by the German 
Research Council (DFG) and the German Ministry for Education and Research (BMBF; Brain 
Imaging Center Frankfurt/Main, DLR 01GO0203). Viola Oertel-Knoechel was supported by 
the Scholarship for Graduate Students of the Goethe-University, Frankfurt/Main, Germany, 
and Anna Rotarska-Jagiela by a doctoral studentship of the Josef Buchmann Foundation. We 
thank the “Angehörigenverband Psychisch Kranker in Hessen” for help with recruitment. DL 
has received consulting honoraria from Actelion Pharmaceuticals Ltd. The other authors 
report no conflict of interest.  
 
 
 
 
Cortical thickness in schizophrenia 
Oertel-Knöchel et al. 
21 
References 
Aggernaes A. 1972. The experienced reality of hallucinations and other psychological 
phenomena. An empirical analysis. Acta psychiatrica Scandinavica 48, 220-238. 
APA. 2000. Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR Fourth 
Edition (Text Revision) American Psychiatric Publishing, Inc. 
Arnold SE, Franz BR, Gur RC, Gur RE, Shapiro RM, Moberg PJ, Trojanowski JQ. 1995. 
Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-
hippocampal interactions. The American journal of psychiatry 152: 738-748. 
Benes FM, Walsh J, Bhattacharyya S, Sheth A, Berretta S. 2003. DNA fragmentation 
decreased in schizophrenia but not bipolar disorder. Archives of general psychiatry 60: 359-
364. 
Bruton CJ, Crow TJ, Frith CD, Johnstone EC, Owens DG, Roberts GW. 1990. Schizophrenia 
and the brain: a prospective clinico-neuropathological study. Psychological medicine 20: 285-
304. 
Calabrese DR, Wang L, Harms MP, Ratnanather JT, Barch DM, Cloninger CR, Thompson PA, 
Miller MI, Csernansky JG. 2008. Cingulate gyrus neuroanatomy in schizophrenia subjects and 
their non-psychotic siblings. Schizophr Res 104: 61-70. 
Callicott JH, Egan MF, Mattay VS, Bertolino A, Bone AD, Verchinksi B, Weinberger DR. 
2003. Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact 
siblings of patients with schizophrenia. The American journal of psychiatry 160: 709-719. 
Cullen TJ, Walker MA, Eastwood SL, Esiri MM, Harrison PJ, Crow TJ. 2006. Anomalies of 
asymmetry of pyramidal cell density and structure in dorsolateral prefrontal cortex in 
schizophrenia. Br J Psychiatry 188: 26-31. 
Dale AM, Fischl B, Sereno MI. 1999. Cortical surface-based analysis, I: segmentation and 
surface reconstruction NeuroImage 9(2): 179-194. 
Dazzan P, Morgan KD, Orr K, Hutchinson G, Chitnis X, Suckling J, Fearon P, McGuire PK, 
Cortical thickness in schizophrenia 
Oertel-Knöchel et al. 
22 
Mallett RM, Jones PB, Leff J, Murray RM. 2005. Different effects of typical and atypical 
antipsychotics on grey matter in first episode psychosis: the AESOP study. 
Neuropsychopharmacology 30: 765-774. 
Deichmann R, Schwarzbauer C, Turner R. 2004. Optimisation of the 3D MDEFT sequence 
for anatomical brain imaging: technical implications at 1.5 und 3T. . NeuroImage 21:757-767. 
DeLisi LE, Szulc KU, Bertisch HC, Majcher M, Brown K. 2006. Understanding structural 
brain changes in schizophrenia. Dialogues in clinical neuroscience 8: 71-78. 
Desikan RS, Segonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, Buckner RL, Dale 
AM, Maguire RP, Hyman BT, Albert MS, Killiany RJ. 2006. An automated labeling system 
for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. 
NeuroImage 31: 968-980. 
Dorph-Petersen KA, Pierri JN, Perel JM, Sun Z, Sampson AR, Lewis DA. 2005. The 
influence of chronic exposure to antipsychotic medications on brain size before and after 
tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. 
Neuropsychopharmacology 30: 1649-1661. 
Egan MF, Hyde TM, Bonomo JB, Mattay VS, Bigelow LB, Goldberg TE, Weinberger DR. 
2001. Relative risk of neurological signs in siblings of patients with schizophrenia. The 
American journal of psychiatry 158: 1827-1834. 
Ehrlich S, Brauns S, Yendiki A, Ho BC, Calhoun V, Schulz SC, Gollub RL, Sponheim SR. 
2011. Associations of Cortical Thickness and Cognition in Patients With Schizophrenia and 
Healthy Controls. Schizophrenia bulletin. 
Ehrlich S, Morrow EM, Roffman JL, Wallace SR, Naylor M, Bockholt HJ, Lundquist A, 
Yendiki A, Ho BC, White T, Manoach DS, Clark VP, Calhoun VD, Gollub RL, Holt DJ. 2010. 
The COMT Val108/158Met polymorphism and medial temporal lobe volumetry in patients 
with schizophrenia and healthy adults. NeuroImage 53: 992-1000. 
Fischl B, Dale AM. 2000. Measuring the thickness of the human cerebral cortex from 
Cortical thickness in schizophrenia 
Oertel-Knöchel et al. 
23 
magnetic resonance images. Proceedings of the National Academy of Sciences of the United 
States of America 97: 11050-11055. 
Fischl B, Liu A, Dale AM. 2001. Automated manifold surgery: constructing geometrically 
accurate and topologically correct models of the human cerebral cortex. . IEEE Trans Med 
Imaging  20(1):70–80. 
Fischl B, Sereno MI, Dale AM. 1999. Cortical surface-based analysis, II: inflation, flattening, 
and a surface-based coordinate system NeuroImage 9(2):195-207. . 
Gaser C, Nenadic I, Volz HP, Buchel C, Sauer H. 2004. Neuroanatomy of "hearing voices": a 
frontotemporal brain structural abnormality associated with auditory hallucinations in 
schizophrenia. Cereb Cortex 14: 91-96. 
Glantz LA, Gilmore JH, Lieberman JA, Jarskog LF. 2006. Apoptotic mechanisms and the 
synaptic pathology of schizophrenia. Schizophr Res 81: 47-63. 
Goghari VM, Rehm K, Carter CS, MacDonald AW. 2007b. Sulcal thickness as a vulnerability 
indicator for schizophrenia. Br J Psychiatry 191: 229-233. 
Goghari VM, Rehm K, Carter CS, MacDonald AW, 3rd. 2007a. Regionally specific cortical 
thinning and gray matter abnormalities in the healthy relatives of schizophrenia patients. 
Cereb Cortex 17: 415-424. 
Gogtay N. 2008. Cortical brain development in schizophrenia: insights from neuroimaging 
studies in childhood-onset schizophrenia. Schizophrenia bulletin 34: 30-36. 
Gogtay N, Greenstein D, Lenane M, Clasen L, Sharp W, Gochman P, Butler P, Evans A, 
Rapoport J. 2007. Cortical brain development in nonpsychotic siblings of patients with 
childhood-onset schizophrenia. Archives of general psychiatry 64: 772-780. 
Goldman AL, Pezawas L, Mattay VS, Fischl B, Verchinski BA, Chen Q, Weinberger DR, 
Meyer-Lindenberg A. 2009. Widespread reductions of cortical thickness in schizophrenia and 
spectrum disorders and evidence of heritability. Archives of general psychiatry 66: 467-477. 
Gottesman, II, Shields J. 1973. Genetic theorizing and schizophrenia. Br J Psychiatry 122: 15-
Cortical thickness in schizophrenia 
Oertel-Knöchel et al. 
24 
30. 
Gottesman I, Gould TD. 2003. The endophenotype concept in psychiatry: etymology and 
strategic intentions. The American journal of psychiatry 160: 636-645. 
Han X, al. e. 2006. Reliability of MRI-derived measurements of human cerebral cortical 
thickness: the effects of field strength, scanner upgrade and manufacturer NeuroImage 32: 
180-194. 
Harms MP, Wang L, Campanella C, Aldridge K, Moffitt AJ, Kuelper J, Ratnanather JT, Miller 
MI, Barch DM, Csernansky JG. 2010. Structural abnormalities in gyri of the prefrontal cortex 
in individuals with schizophrenia and their unaffected siblings. Br J Psychiatry 196: 150-157. 
Harrison PJ. 1999. The neuropathology of schizophrenia. A critical review of the data and 
their interpretation. Brain 122 ( Pt 4): 593-624. 
Harrison PJ, Weinberger DR. 2005. Schizophrenia genes, gene expression, and 
neuropathology: on the matter of their convergence. . Mol Psychiatry 10(1):40–68. 5. 
Hartberg CB, Lawyer G, Nyman H, Jonsson EG, Haukvik UK, Saetre P, Bjerkan PS, 
Andreassen OA, Hall H, Agartz I. 2010. Investigating relationships between cortical thickness 
and cognitive performance in patients with schizophrenia and healthy adults. Psychiatry 
research 182: 123-133. 
Haukvik UK, Lawyer G, Bjerkan PS, Hartberg CB, Jonsson EG, McNeil T, Agartz I. 2009. 
Cerebral cortical thickness and a history of obstetric complications in schizophrenia. Journal 
of psychiatric research 43: 1287-1293. 
Henn FA, Braus DF. 1999. Structural neuroimaging in schizophrenia: an integrative view of 
neuromorphology. Eur Arch Psychiatry Clin Neurosci  249(4) 48-56. 
Honea R, Crow TJ, Passingham D, Mackay CE. 2005. Regional deficits in brain volume in 
schizophrenia: a meta-analysis of voxel-based morphometry studies. The American journal of 
psychiatry 162: 2233–2245. 
Jarskog LF, Selinger ES, Lieberman JA, Gilmore JH. 2004. Apoptotic proteins in the temporal 
Cortical thickness in schizophrenia 
Oertel-Knöchel et al. 
25 
cortex in schizophrenia: high Bax/Bcl-2 ratio without caspase-3 activation. The American 
journal of psychiatry 161: 109-115. 
Kay SR, Fiszbein A, Opler LA. 1987. The Positive und Negative Symptom Scale (PANSS) 
for Schizophrenia.  . Schizophrenia Bulletin 13:261-76. 
Kendler KS, McGuire M, Gruenberg AM, Walsh D. 1995. Schizotypal symptoms and signs in 
the Roscommon Family Study. Their factor structure and familial relationship with psychotic 
and affective disorders. Archives of general psychiatry 52: 296-303. 
Keshavan MS, Tandon R, Boutros NN, Nasrallah HA. 2008. Schizophrenia, "just the facts": 
what we know in 2008 Part 3: neurobiology. Schizophr Res 106: 89-107. 
Klein C, et al. 1997. Erfassung der schizotypen Persönlichkeit nach DSM-III-R: 
Psychometrische Eigenschaften einer autorisierten deutschsprachigen Übersetzung des 
„Schizotypy Personality Questionnaire“ (SPQ) von Raine. . Diagnostica 43, 347-369. 
Kruggel F, Turner J, Muftuler LT. 2010. Impact of scanner hardware and imaging protocol on 
image quality and compartment volume precision in the ADNI cohort. NeuroImage 49: 2123-
2133. 
Kubota M, Miyata J, Yoshida H, Hirao K, Fujiwara H, Kawada R, Fujimoto S, Tanaka Y, 
Sasamoto A, Sawamoto N, Fukuyama H, Murai T. 2011. Age-related cortical thinning in 
schizophrenia. Schizophr Res 125: 21-29. 
Kuperberg GR, Broome MR, McGuire PK, David AS, Eddy M, Ozawa F, Goff D, West WC, 
Williams SC, van der Kouwe AJ, Salat DH, Dale AM, Fischl B. 2003. Regionally localized 
thinning of the cerebral cortex in schizophrenia. Archives of general psychiatry 60: 878-888. 
Lawyer G, Nesvag R, Varnas K, Frigessi A, Agartz I. 2008. Investigating possible subtypes of 
schizophrenia patients and controls based on brain cortical thickness. Psychiatry research 164: 
254-264. 
Levitan C, Ward PB, Catts SV. 1999. Superior temporal gyral volumes and laterality 
correlates of auditory hallucinations in schizophrenia. Biological psychiatry 46: 955-962. 
Cortical thickness in schizophrenia 
Oertel-Knöchel et al. 
26 
Magnotta VA, Andreasen NC, Schultz SK, Harris G, Cizadlo T, Heckel D, Nopoulos P, Flaum 
M. 1999. Quantitative in vivo measurement of gyrification in the human brain: changes 
associated with aging. Cereb Cortex 9: 151-160. 
Mass R, Haasen C, Wolf K. 2000. Das Eppendorfer Schizophrenie-Inventar (ESI). 
Entwicklung und Evaluation eines Fragebogens zur Erfassung charakteristischer 
Selbstwahrnehmungen kognitiver Dysfunktionen schizophren Erkrankter. Der Nervenarzt 71 
(11)  
885-892. 
Mattai A, Hosanagar A, Weisinger B, Greenstein D, Stidd R, Clasen L, Lalonde F, Rapoport J, 
Gogtay N. 2011. Hippocampal volume development in healthy siblings of childhood-onset 
schizophrenia patients. The American journal of psychiatry 168: 427-435. 
Meyer-Lindenberg A. 2009. Widespread Reductions of Cortical Thickness in Schizophrenia 
and Spectrum Disorders and Evidence of Heritability. . Arch Gen Psychiatry 66 467–477. 
Morrison AP, Wells A, Nothard S. 2002. Cognitive and emotional predictors of predisposition 
to hallucinations in non-patients.  . British Journal of Clinical Psychology 41(3), 259-270. 
Murakami M, Hidemasa T, Osamu A, Yamasue H, Sasaki H, et al. . 2010. Cortical thickness, 
gray matter volume, and white matter anisotropy and diffusivity in schizophrenia 
Neuroradiology  
Narr KL, Bilder RM, Toga AW, al. e. 2005. Mapping cortical thickness and gray matter 
concentration in first episode schizophrenia. . Cereb Cortex 15(6):708–719. . 
Nichols TE, Holmes AP. 2002. Nonparametric permutation tests for functional neuroimaging: 
a primer with examples. Human brain mapping 15: 1-25. 
Oertel V, Knöchel C, Rotarska-Jagiela A, Schönmeyer R, van de Ven V, Haenschel C, Uhlhaas 
P, Maurer K, Linden DEJ. 2010. Reduced laterality as a trait marker of schizophrenia--
evidence from structural and functional neuroimaging. J Neurosci 30: 2289-2299. 
Oertel V, Rotarska-Jagiela A, van de Ven V, Haenschel C, Grube M, Stangier U, Maurer K, 
Cortical thickness in schizophrenia 
Oertel-Knöchel et al. 
27 
Linden DE. 2009. Mental imagery vividness as a trait marker across the schizophrenia 
spectrum. Psychiatry research 167: 1-11. 
Oldfield RC. 1971. The assessment and analysis of handedness: the Edinburgh inventory. 
Neuropsychologia 9: 97-113. 
Pakkenberg B. 1993. Total nerve cell number in neocortex in chronic schizophrenics and 
controls estimated using optical disectors. Biological psychiatry 34: 768-772. 
Pereira JB, Ibarretxe-Bilbao N, Marti MJ, Compta Y, Junque C, Bargallo N, Tolosa E. 2011. 
Assessment of cortical degeneration in patients with parkinson's disease by voxel-based 
morphometry, cortical folding, and cortical thickness. Human brain mapping. 
Pezawas L, Quiner S, Moertl D, Tauscher J, Barnas C, Kufferle B, Wolf R, Kasper S. 2000. 
Efficacy, cardiac safety and tolerability of sertindole: a drug surveillance. International 
clinical psychopharmacology 15: 207-214. 
Prvulovic D, Hubl D, Sack AT, Melillo L, Maurer K, Frolich L, Lanfermann H, Zanella FE, 
Goebel R, Linden DE, Dierks T. 2002. Functional imaging of visuospatial processing in 
Alzheimer's disease. NeuroImage 17: 1403-1414. 
Raine A. 1991. The SPQ: A scale for the assessment of schizotypal personality based on 
DSM-III-R criteria Schizophrenia bulletin 17 556-564. 
Rajkowska G, Selemon LD, Goldman-Rakic PS. 1998. Neuronal and glial somal size in the 
prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. 
Archives of general psychiatry 55: 215-224. 
Rakic P. 2008. Confusing cortical columns. Proceedings of the National Academy of Sciences 
of the United States of America 105: 12099-12100. 
Repovs G, Csernansky JG, Barch DM. 2011. Brain network connectivity in individuals with 
schizophrenia and their siblings. Biological psychiatry 69: 967-973. 
Rosas HD, et al. 2002. Regional and progressive thinning of the cortical ribbon in 
Huntington’s disease. Neurology Neurology 58(5):695–701. . 
Cortical thickness in schizophrenia 
Oertel-Knöchel et al. 
28 
Rotarska-Jagiela A, et al. 2009. Anatomical brain connectivity and positive symptoms of 
schizophrenia: a diffusion tensor imaging study. . Psychiatry research 174:9-16. 
Salat DH, Buckner RL, Snyder AZ, Greve DN, Desikan RS, Busa E, Morris JC, Dale AM, 
Fischl B. 2004. Thinning of the cerebral cortex in aging. Cereb Cortex 14: 721-730. 
Segonne F, Dale AM, Busa E, Glessner M, Salat D, Hahn HK, Fischl B. 2004. A hybrid 
approach to the skull stripping problem in MRI. NeuroImage 22: 1060-1075. 
Segonne F, Grimson E, Fischl B. 2005. A genetic algorithm for the topology correction of 
cortical surfaces. Inf Process Med Imaging 19: 393-405. 
Selemon LD, Rajkowska G, Goldman-Rakic PS. 1995. Abnormally high neuronal density in 
the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. 
Archives of general psychiatry 52: 805-818; discussion 819-820. 
Selemon LD, Rajkowska G, Goldman-Rakic PS. 1998. Elevated neuronal density in prefrontal 
area 46 in brains from schizophrenic patients: application of a three-dimensional, stereologic 
counting method. The Journal of comparative neurology 392: 402-412. 
Shields J, Gottesman, II. 1972. Cross-national diagnosis of schizophrenia in twins. The 
heritability and specificity of schizophrenia. Archives of general psychiatry 27: 725-730. 
Sowell ER, Delis D, Stiles J, Jernigan TL. 2001. Improved memory functioning and frontal 
lobe maturation between childhood and adolescence: a structural MRI study. J Int 
Neuropsychol Soc 7: 312-322. 
Sowell ER, Peterson BS, Thompson PM, Welcome SE, Henkenius AL, Toga AW. 2003. 
Mapping cortical change across the human life span. Nature neuroscience 6: 309-315. 
Sumich A, Chitnis XA, Fannon DG, O'Ceallaigh S, Doku VC, Faldrowicz A, Sharma T. 2005. 
Unreality symptoms and volumetric measures of Heschl's gyrus and planum temporal in first-
episode psychosis. Biological psychiatry 57: 947-950. 
Tepest R, Vogeley K, Viebahn B, Schneider-Axmann T, Honer WG, Falkai P. 2008. 
Automated gray level index measurements reveal only minor cytoarchitectonic changes of 
Cortical thickness in schizophrenia 
Oertel-Knöchel et al. 
29 
Brodmann area 9 in schizophrenia. Psychiatry research 163: 183-192. 
Thompson PM, et al. 2004. Mapping cortical change in Alzheimer’s disease, brain 
development, and schizophrenia. . NeuroImage 23 suppl 1:S2–S18. 
Thompson PM, Hayashi KM, Sowell ER, Gogtay N, Giedd JN, Rapoport JL, de Zubicaray 
GI, Janke AL, Rose SE, Semple J, Doddrell DM, Wang Y, van Erp TG, Cannon TD, Toga AW. 
2004. Mapping cortical change in Alzheimer's disease, brain development, and schizophrenia. 
NeuroImage 23 Suppl 1: S2-18. 
Tost H, Braus DF, Hakimi S, Ruf M, Vollmert C, Hohn F, Meyer-Lindenberg A. 2010. Acute 
D2 receptor blockade induces rapid, reversible remodeling in human cortical-striatal circuits. 
Nature neuroscience 13: 920-922. 
Van Os J, Jones PB. 2001. Neuroticism as a risk factor for schizophrenia. Psychological 
medicine 31: 1129-1134. 
Venkatasubramanian G, Jayakumar PN, Gangadhar BN, Keshavan MS. 2008. Automated MRI 
parcellation study of regional volume and thickness of prefrontal cortex (PFC) in 
antipsychotic-naive schizophrenia. Acta psychiatrica Scandinavica 117: 420-431. 
Venkatasubramanian G, Jayakumar PN, Keshavan MS, Gangadhar BN. 2011. Schneiderian 
first rank symptoms and inferior parietal lobule cortical thickness in antipsychotic-naive 
schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry 35: 40-46. 
Vogeley K, Hobson T, Schneider-Axmann T, Honer WG, Bogerts B, Falkai P. 1998. 
Compartmental volumetry of the superior temporal gyrus reveals sex differences in 
schizophrenia--a post-mortem study. Schizophr Res 31: 83-87. 
Weinberger DR, Lipska BK. 1995. Cortical maldevelopment, anti-psychotic drugs, and 
schizophrenia: a search for common ground. . Schizophr Res 16(2):87–110. . 
White T, Andreasen NC, Nopoulos P, Magnotta V. 2003. Gyrification abnormalities in 
childhood- and adolescent-onset schizophrenia  Biological psychiatry 54(4): : 418-426. 
Wiegand LC. 2004. Prefrontal cortical thickness in first-episode psychosis: a magnetic 
Cortical thickness in schizophrenia 
Oertel-Knöchel et al. 
30 
resonance imaging study.  . Biol Psychiatry 55(2):131–140. 
Wittchen HU, Zhao S, Abelson JM, Abelson JL, Kessler RC. 1996. Reliability and procedural 
validity of UM-CIDI DSM-III-R phobic disorders. Psychological medicine 26: 1169-1177. 
Wood SJ, Pantelis C, Velakoulis D, Yucel M, Fornito A, McGorry PD. 2008. Progressive 
changes in the development toward schizophrenia: studies in subjects at increased 
symptomatic risk. Schizophrenia bulletin 34: 322-329. 
Woods SW. 2003. Chlorpromazine equivalent doses for the newer atypical antipsychotics. The 
Journal of clinical psychiatry 64: 663-667. 
Wright IC, et al. 2000. Meta-analysis of regional brain volumes in schizophrenia. The 
American journal of psychiatry 157: 16-25. 
Yang Y, Nuechterlein KH, Phillips O, Hamilton LS, Subotnik KL, Asarnow RF, Toga AW, 
Narr KL. 2010. The contributions of disease and genetic factors towards regional cortical 
thinning in schizophrenia: the UCLA family study. Schizophr Res 123: 116-125. 
 
 
Cortical thickness in schizophrenia 
Oertel-Knöchel et al. 
31 
Table 1: Sociodemographic and clinical variables across all groups (SZ patients, relatives, 
controls). Abbreviations: PAT = SZ patients, REL = first-degree relatives, CON = healthy 
controls.  
 PAT REL CON F test (One-way 
ANOVA) 
N 31 29 37 97 
Gender 15 female, 16 
male 
15 female, 14 
male 
20 female, 17 
male 
 
Years of 
education** 
14.26 (2.57) 15.05 (4.12) 16.05 (2.63) 
 
Parental 
Education 
(years, SD) 
 
Mother:  
12.84 (2.36) 
Father:  
12.93 (2.70) 
Mother:  
12.69 (2.24) 
Father:  
13.72 (3.01) 
Mother:  
12.92 (2.79) 
Father:  
13.40 (3.00) 
 
Age (years, SD) 38.00 (11.24) 40.38 (15.84) 39.36 (9.97)  
Handedness All right-
handed 
All right-
handed 
All-right 
handed 
 
RHS 
(mean) 
Significance 
33.31 (4.87) 
PAT / REL:  
p = 0.03 
27.50 (5.66) 
REL / CON: 
n.s. 
23.67 (3.02) 
PAT / CON: 
p < 0.01 
F (2, 95) = 8.99, 
p< 0.01 
ESI (mean, SD) 
 
22.31 (6.17) 
PAT / REL: 
p < 0.01 
10.87 (8.08) 
REL / CON: 
n.s. 
5.64 (0.70) 
PAT / CON: 
p < 0.01 
F (2, 95) = 19.80, 
p<0.01 
SPQ (mean, SD) 
 
 13.02 (6.13) 4.57 (1.54) 
REL / CON  
< 0.01 
F (1, 65) = 43.18, 
p <0 .01 
SPQ cognitive-
perceptual factor 
(mean, SD)  
 7.34 (4.03) 2.45 (1.14) 
REL / CON 
< 0.01 
F (1, 65) = 45.65, 
p < 0.01 
SPQ interpers. 
factor  
(mean, SD) 
 4.23 (2.32) 4.98 (2.43) 
REL / CON 
n.s. 
F(1, 65) =19.15 
p <0 .01 
Diagnosis Paranoid SZ 
(DSM-IV 
criteria 295.30 
[APA, 1994]) 
   
History of 
hallucinations 
All (n = 25) 
history of 
hallucinations 
→ n = 12: this 
episode, 6 of 
them in the 
week of the 
measurement 
→ n = 13:  
earlier episode 
   
Age of onset 24.43 (6.63)    
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Years of illness 13.71 (6.87)    
Medication 27 atypical 
4 atypical and 
typical,  
   
PANSS Positive  
15.69 (3.20), 
Negative  
15.13 (1.78),  
General  
32.06 (4.07),  
Sum  
62.75 (5.30), 
Hallucination: 
3.08 (1.40) 
   
P = significant on a > 0.05-threshold.  
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Table 2: The table contains all regions which showed significant differences in cortical 
thickness (in mm) across groups (group contrast; left column). The middle rows shows in all 
significant areas mean values (in mm) of cortical thickness across groups. The table shows 
also post-hoc single contrast analysis between all groups (right column). All areas, which 
show a significant continuum of controls, relatives and patients are highlighted in bold face. 
Abbreviations: BA = Brodmann area, l. = left, r. = right, inf. = inferior, sup. = superior.  
Region 
(BA) 
PAT 
Mean 
mm (SD) 
REL 
Mean 
mm (SD) 
CON 
Mean 
mm (SD) 
Significance 
F, p 
L. inf. frontal gyrus (45/46/47)  2.11 (0.24) 
 
2.56 (0.22) 
 
2.51 (0.22) 
 
CON/PAT: F(95) = 6.19, p = 0.02  
REL/ PAT: F(95) = 6.95, p = 0.01 
CON/ REL: n.s. 
R. inf. frontal gyrus (45) 2.03 (0.12) 2.34 (0.18) 
 
 
2.35 (0.29) 
 
 
CON/PAT: F(95) = 5.53, p = 0.03  
REL/PAT: F(95)=7.65, p =  0.01 
CON/REL: n.s. 
R. inf. frontal gyrus (9) 1.89 (0.14) 
 
 
2.01 (0.14) 
 
 
2.88 (0.21)  
 
 
CON/PAT: F(95) = 8.71, p < 0.01 
REL/PAT: F(95)=17.56, p < 0.01 
CON/REL: F(95)=12.70, p< 0.01 
L. mid. frontal gyrus (6,10)  2.10 (0.15) 
  
2.08 (0.22) 
 
2.79 (0.18) 
 
CON/PAT: F (95) = 8.07, p <0.01 
REL/PAT: n.s. 
CON/REL: F(95) = 6.79, p= 0.02 
R. middle frontal gyrus (6,10) 2.44 (0.29) 2.35 (0.24) 
 
2.98 (0.31) 
 
CON/PAT: F(95)= 4.65, p = 0.04 
F(95) = 7.71, p = 0.01  
REL/PAT: n.s.  
CON/REL: F(95) = 5.57, p= 0.03 
L. precentral gyrus (4)  2.36 (0.14) 
 
2.35 (0.25) 
 
2.78 (0.22)  CON/PAT: F(95) = 6.31, p = 0.02  
REL/PAT: n.s. 
CON/REL: F(95)= 4.43, p = 0.04 
R. precentral gyrus (6) 2.65 (0.26) 
 
3.01 (0.22) 
 
3.33 (0.34) 
 
CON/PAT: F(95)=8.07, p < 0.01 
REL/PAT: F(95) = 6.55, p = 0.02 
CON/REL: F(95) = 8.12, p= 0.01 
L. inf. temporal gyrus (20)  2.03 (0.14)  
 
 
2.87 (0.18) 
 
3.21 (0.45) 
 
 
CON/PAT: F(95) = 6.98, p =0.01  
REL/PAT:F(95) = 11.31, p < 0.01  
CON/REL: F (95)= 5.43, p= 0.02 
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R. middle temporal gyrus 
(21) 
1.97 (0.21) 
 
2.78 (0.22) 
 
3.02 (0.11) 
 
CON/PAT: F(95)=14.51, p < 0.01 
CON/ REL: F(95)= 4.01, p= 0.04 
REL / PAT: F(95) =6.33, p< 0.01 
L. sup. temporal gyrus (41) 2.82 (0.59) 3.55 (0.43) 3.98  
(0.13) 
CON/PAT: F(95)= 16.46, p< 0.01 
CON/REL: F(95) = n.s.  
REL/PAT: F(95)= 15.07, p < 0.01 
R. sup. temporal gyrus (41) 2.46 (0.15) 2.69 (0.25) 
 
 
2.97 (0.17) 
 
CON/ PAT: F(95)= 4.43, p = 0.04  
CON/REL: F(95) = 4.91, p= 0.04 
REL/PAT : n.s. 
L. inf. parietal lobule (40)  2.14 (0.18) 
 
2.34 (0.14) 2.82 (0.59) 
 
CON/PAT: F(95) = 6.89, p = 0.02  
CON/REL:F(95)= 14.19, p< 0.01 
REL/PAT: n.s. 
L. sup. parietal lobule (7)  1.99 (0.19)  
 
2.05 (0.16) 
 
2.34 (0.15)  
 
CON/PAT: F(95) = 8.57, p = 0.01  
CON/REL: F(95)= 5.31, p = 0.03  
REL/PAT: F(95) = 9.85, p < 0.01 
R. sup. parietal lobule (7) 2.03 (0.23) 
 
2.97 (0.17) 
 
3.55 (0.43) 
 
CON/PAT: F(95)= 28.06, p< 0.01  
CON/REL: F(95) = 4.01, p= 0.04 
REL/PAT: F (95) = 6.65, p = 0.02 
L. lingual gyrus (19) 2.35 (0.14) 
 
2.56 (0.23) 
 
2.96 (0.32) 
 
CON/PAT: F(95) = 8.70, p < 0.01  
CON/REL: F(95) = 9.32, p< 0.01  
REL/PAT: 7.31, p = 0.01 
R. lingual gyrus (19) 2.30 (0.22) 
 
2.94 (0.13) 3.13 (0.21) 
 
CON/PAT: F(95)=19.30, p< 0.01 
CON/REL: n.s. 
REL/PAT: F(95): 8.88, p < 0.01 
R. insula 2.17 (0.18) 
 
2.34 (0.10) 
 
 
2.86 (0.21) 
 
CON/PAT: F(95)=14.19, p<  0.01  
CON/REL: F (95)= 5.81, p= 0.03  
REL/PAT: n.s. 
L. para-hippocampal gyrus, 
Hippocampus (36)  
2.36 (0.21) 
 
2.66 (0.13) 
 
2.95 (0.16)  
 
CON/PAT: F(95) = 9.98, p < 0.01  
CON/REL: F(95)= 8.07, p = 0.01 
REL / PAT: n.s. 
Right parahippocampal gyrus / 
hippocampus (36) 
1.97 (0.19) 
 
2.01 (0.13) 
 
2.43 (0.14) 
 
CON/PAT: F(95) = 7.12, p = 0.01 
CON/REL: F(95) =5.28, p = 0.04  
REL / PAT: n.s. 
L. anterior cingulate, (24)  2.15 (0.12) 
 
2.35 (0.14) 
 
2.82 (0.29) 
 
CON/PAT: F(95) = 9.53, p < 0.01  
CON/REL: F(95) = 8.18, p< 0.01 
REL/PAT: n.s. 
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Figure legend:  
Figure 1: Statistical comparisons between all groups. The upper three rows show group 
comparisons between controls and patients, controls and relatives and relatives and patients in 
the left hemisphere, the lower three rows show group comparisons between controls and 
patients, controls and relatives and relatives and patients in the right hemisphere. The color 
bars denote t values (red: higher activation in the first compared to the second group of each 
contrast). 
 
 
 
 
 
 
 
